Cardiac failure chronic and Mobility decreased
Summary:
Mobility decreased is found among people with Cardiac failure chronic, especially for people who are male, 60+ old.
The study analyzes which people have Mobility decreased with Cardiac failure chronic. It is created by eHealthMe based on reports of 47 people who have Cardiac failure chronic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Cardiac failure chronic?
Cardiac failure chronic is found to be associated with 474 drugs and 515 conditions by eHealthMe. Check the latest studies of Cardiac failure chronic.
What is Mobility decreased?
Mobility decreased (ability to move is reduced) is found to be associated with 1,774 drugs and 1,632 conditions by eHealthMe. Check the latest studies of Mobility decreased.
47 people who have Cardiac Failure Chronic and Mobility Decreased are studied.

Gender of people who have Cardiac Failure Chronic and experienced Mobility Decreased *:
- female: 36.96 %
- male: 63.04 %
Age of people who have Cardiac Failure Chronic and experienced Mobility Decreased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 7.14 %
- 60+: 92.86 %
Common co-existing conditions for these people *:
- Pain: 14 people, 29.79%
- High Blood Cholesterol: 12 people, 25.53%
- High Blood Pressure: 5 people, 10.64%
- Cardiac Disorder: 3 people, 6.38%
- Cardiac Failure: 3 people, 6.38%
- Thyroid Diseases: 3 people, 6.38%
- Neck Pain: 2 people, 4.26%
- Iron Deficiency Anaemia: 2 people, 4.26%
- Blood Uric Acid Abnormal: 2 people, 4.26%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 4.26%
Common drugs taken by these people *:
- Entresto: 21 people, 44.68%
- Aldactone: 12 people, 25.53%
- Diclofenac: 10 people, 21.28%
- Symbicort: 5 people, 10.64%
- Voltaren: 5 people, 10.64%
- Magnesium: 4 people, 8.51%
- Xarelto: 4 people, 8.51%
- Lasix: 3 people, 6.38%
- Synthroid: 3 people, 6.38%
- Clopidogrel: 3 people, 6.38%
Common symptoms for these people *:
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 18 people, 38.30%
- Renal Impairment (severely reduced kidney function): 16 people, 34.04%
- Dyspnea (difficult or laboured breathing): 16 people, 34.04%
- Pain In Extremity: 16 people, 34.04%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 15 people, 31.91%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 14 people, 29.79%
- Weight Decreased: 13 people, 27.66%
- Heart Rate Increased: 13 people, 27.66%
- Weakness: 13 people, 27.66%
- Type 2 Diabetes: 11 people, 23.40%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Mobility decreased?
- Check whether Mobility decreased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Cardiac failure chronic (16,387 reports)
- Mobility decreased (83,538 reports)
All the drugs that are associated with Mobility decreased:
- Mobility decreased (1,774 drugs)
All the conditions that are associated with Mobility decreased:
- Mobility decreased (1,632 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Mobility decreased and Cardiac failure chronic, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Raptiva cause Hair Loss? - 9 seconds ago
- Drug interactions of Combivent and Famotidine - 38 seconds ago
- Drug interactions of Coreg and Protamine Sulfate - 43 seconds ago
- Buspirone Hcl vs. L-Tyrosine, side effect and effectiveness comparison - 53 seconds ago
- Could Ondansetron cause Impetigo? - 56 seconds ago
- Could Uloric cause Swelling? - 57 seconds ago
- Could Implanon cause High Blood Pressure? - 58 seconds ago
- Could Celebrex cause Broken Bone? - a minute ago
- Could Zide cause Hot Flushes Aggravated? - a minute ago
- Drug interactions of Avinza and Advair Hfa - a minute ago